Alexander Rotenberg is a neurologist and epileptologist, and Director of the Neuromoduation Program within the department of Neurology. He is also presently president of the Greater Boston Epilepsy Society. Dr. Rotenberg leads local efforts to adapt methods for transcranial magnetic stimulation (TMS) and other forms of noninvasive brain stimulation to the pediatric population, particularly to children with epilepsy. He also heads a basic science laboratory where experiments focus on translational applications of noninvasive brain stimulation in animal models of epilepsy and brain injury. Among his ongoing scientific studies are clinical trials aimed to test the capacity of TMS and related methods for brain stimulation to stop drug-resistant seizures, clinical studies of human brain plasticity in autism, and preclinical studies aimed to describe the neurobiology of a range of brain stimulation in order to improve their efficacy in clinical practice. Dr. Rotenberg’s research is supported by the National Institute of Health, Boston Children’s Hospital Translational Research Program, Department of Defense, and industry.